Brian Hee

492 total citations
17 papers, 406 citations indexed

About

Brian Hee is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brian Hee has authored 17 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brian Hee's work include Hedgehog Signaling Pathway Studies (7 papers), Oral and gingival health research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Brian Hee is often cited by papers focused on Hedgehog Signaling Pathway Studies (7 papers), Oral and gingival health research (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Brian Hee collaborates with scholars based in United States, China and Belgium. Brian Hee's co-authors include Yazdi K. Pithavala, May Garrett, Karen J. Klamerus, Michael A. Tortorici, Robert R. LaBadie, M. Naveed Shaik, Ying Chen, Paulina Selaru, Sadayappan V. Rahavendran and Hua Wei and has published in prestigious journals such as Cancer Research, Clinical Pharmacokinetics and British Journal of Clinical Pharmacology.

In The Last Decade

Brian Hee

16 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Hee United States 11 207 159 136 69 64 17 406
Kristell Marzin Germany 11 169 0.8× 312 2.0× 196 1.4× 52 0.8× 17 0.3× 18 545
Cynthia M. Nijenhuis Netherlands 14 172 0.8× 107 0.7× 202 1.5× 113 1.6× 26 0.4× 28 535
Martine Hubert France 12 120 0.6× 80 0.5× 184 1.4× 153 2.2× 34 0.5× 15 591
Anshu Marathe United States 11 183 0.9× 112 0.7× 203 1.5× 29 0.4× 55 0.9× 22 559
Hiromi Tanii Japan 12 340 1.6× 57 0.4× 269 2.0× 62 0.9× 43 0.7× 19 536
J. A. Ware United States 10 317 1.5× 215 1.4× 218 1.6× 61 0.9× 32 0.5× 23 599
Patricia Creel United States 11 218 1.1× 294 1.8× 192 1.4× 32 0.5× 101 1.6× 24 507
Vikram Malhi United States 11 234 1.1× 52 0.3× 130 1.0× 29 0.4× 22 0.3× 23 427
Djoeke de Wit Netherlands 11 144 0.7× 141 0.9× 192 1.4× 103 1.5× 33 0.5× 13 450
Claudia Dallinger Germany 8 156 0.8× 326 2.1× 115 0.8× 18 0.3× 22 0.3× 10 582

Countries citing papers authored by Brian Hee

Since Specialization
Citations

This map shows the geographic impact of Brian Hee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Hee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Hee more than expected).

Fields of papers citing papers by Brian Hee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Hee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Hee. The network helps show where Brian Hee may publish in the future.

Co-authorship network of co-authors of Brian Hee

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Hee. A scholar is included among the top collaborators of Brian Hee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Hee. Brian Hee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Purohit, Vivek S., et al.. (2025). Drug–drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450. British Journal of Clinical Pharmacology. 91(8). 2316–2326.
2.
Bauman, Jonathan, Angela C. Doran, Brian Hee, et al.. (2024). The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Ritlecitinib, a Janus Kinase 3 and Tyrosine-Protein Kinase Family Inhibitor, in Humans. Drug Metabolism and Disposition. 52(10). 1124–1136. 7 indexed citations
3.
Shaik, M. Naveed, Robert R. LaBadie, Brian Hee, & Geoffrey Chan. (2021). Evaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers. Cancer Chemotherapy and Pharmacology. 87(2). 241–250. 3 indexed citations
4.
Masters, Joanna C., et al.. (2020). Clinical and Model‐Based Evaluation of the Effect of Glasdegib on Cardiac Repolarization From a Randomized Thorough QT Study. Clinical Pharmacology in Drug Development. 10(3). 272–282. 3 indexed citations
5.
Garrett, May, Ana Ruiz-Garcı́a, Kourosh Parivar, Brian Hee, & Joseph Boni. (2019). Population pharmacokinetics of inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma. Journal of Pharmacokinetics and Pharmacodynamics. 46(3). 211–222. 26 indexed citations
6.
Shaik, M. Naveed, Brian Hee, Yali Liang, & Robert R. LaBadie. (2019). Absolute Oral Bioavailability of Glasdegib (PF‐04449913), a Smoothened Inhibitor, in Randomized Healthy Volunteers. Clinical Pharmacology in Drug Development. 8(7). 895–902. 8 indexed citations
7.
Shaik, M. Naveed, Brian Hee, Hua Wei, & Robert R. LaBadie. (2018). Evaluation of the effects of formulation, food, or a proton-pump inhibitor on the pharmacokinetics of glasdegib (PF-04449913) in healthy volunteers: a randomized phase I study. Cancer Chemotherapy and Pharmacology. 83(3). 463–472. 17 indexed citations
8.
Shaik, M. Naveed, Brian Hee, Hua Wei, & Robert R. LaBadie. (2018). Evaluation of the effect of rifampin on the pharmacokinetics of the Smoothened inhibitor glasdegib in healthy volunteers. British Journal of Clinical Pharmacology. 84(6). 1346–1353. 19 indexed citations
9.
Giri, Nagdeep, Lisa H. Lam, Robert R. LaBadie, et al.. (2017). Evaluation of the effect of new formulation, food, or a proton pump inhibitor on the relative bioavailability of the smoothened inhibitor glasdegib (PF-04449913) in healthy volunteers. Cancer Chemotherapy and Pharmacology. 80(6). 1249–1260. 12 indexed citations
10.
Lam, Justine L., Alfin D. N. Vaz, Brian Hee, et al.. (2016). Metabolism, excretion and pharmacokinetics of [14C]glasdegib (PF-04449913) in healthy volunteers following oral administration. Xenobiotica. 47(12). 1064–1076. 21 indexed citations
11.
Smith, Bill J., Yazdi K. Pithavala, Hai‐Zhi Bu, et al.. (2014). Pharmacokinetics, Metabolism, and Excretion of [14C]Axitinib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Humans. Drug Metabolism and Disposition. 42(5). 918–931. 31 indexed citations
12.
Chen, Ying, Michael A. Tortorici, May Garrett, et al.. (2013). Clinical Pharmacology of Axitinib. Clinical Pharmacokinetics. 52(9). 713–725. 99 indexed citations
13.
Garrett, May, Bill Poland, Meghan Brennan, et al.. (2013). Population pharmacokinetic analysis of axitinib in healthy volunteers. British Journal of Clinical Pharmacology. 77(3). 480–492. 21 indexed citations
14.
Pithavala, Yazdi K., Ying Chen, Melvin Toh, et al.. (2012). Evaluation of the effect of food on the pharmacokinetics of axitinib in healthy volunteers. Cancer Chemotherapy and Pharmacology. 70(1). 103–112. 36 indexed citations
15.
Pithavala, Yazdi K., Sadayappan V. Rahavendran, May Garrett, et al.. (2010). Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers. Investigational New Drugs. 30(1). 273–281. 53 indexed citations
16.
Tortorici, Michael A., Melvin Toh, Sadayappan V. Rahavendran, et al.. (2010). Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics. Investigational New Drugs. 29(6). 1370–1380. 47 indexed citations
17.
Pithavala, Yazdi K., Melvin Toh, May Garrett, et al.. (2008). Effect of food on the pharmacokinetics of Axitinib (AG-013736) in healthy volunteers. Cancer Research. 68. 233–233. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristell Marzin Breakdown of academic impact, for papers by Cynthia M. Nijenhuis Breakdown of academic impact, for papers by Martine Hubert Breakdown of academic impact, for papers by Anshu Marathe Breakdown of academic impact, for papers by Hiromi Tanii Breakdown of academic impact, for papers by J. A. Ware Breakdown of academic impact, for papers by Patricia Creel Breakdown of academic impact, for papers by Vikram Malhi Breakdown of academic impact, for papers by Djoeke de Wit Breakdown of academic impact, for papers by Claudia Dallinger
Rankless by CCL
2026